Loading...
01/11 08:10
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several negative indicators: a significant net loss, declining revenue, and strategic uncertainties due to paused projects and supply constraints. The Q&A session highlighted competitive pressures and uncertain timelines for new product development. Although Hitrans showed revenue growth, it was insufficient to offset overall losses. The absence of a clear shareholder return plan and the dependency on delayed expansions further dampen sentiment. These factors, coupled with a strategic transition impacting revenues, suggest a negative stock price reaction in the short term.
Net Revenue $40.52 million, down 15% year-over-year from $47.79 million in 2024. The decline was primarily driven by a sharp reduction in sales to customers in the residential energy storage market, which fell by 44.8% year-over-year due to the transition from Model 26650 to Model 40135 batteries.
Net Loss Attributable to Shareholders $3.07 million. This loss was attributed to the strategic transition to a larger, more advanced battery model, which impacted revenues.
Total Net Loss $3.36 million. The battery segment accounted for $2.07 million in net losses, while the raw materials production unit, Hitrans, reported net losses of $1.06 million.
Hitrans Net Revenue $19.43 million, up 59.36% year-over-year from $12.9 million in 2024. The improvement was driven by Hitrans' efforts to expand its market presence, secure new customers, and a modest decline in raw material prices, which stimulated demand.
Hitrans Net Loss $1.06 million, narrowed by 33.02% year-over-year from $1.56 million in 2024. This improvement reflects Hitrans' sustained market expansion and increased customer demand.
Transition to Model 40135: Dalian facility is transitioning from Model 26650 to Model 40135, a larger and more advanced battery model. This has caused a sharp decline in Dalian's net revenues and gross profit.
Model 32140 Demand: Nanjing facility is facing supply constraints due to surging demand for Model 32140 cells. Phase 1 is at full capacity, and Phase 2 completion has been delayed to Q4.
Market Shift: Sales to the residential energy storage market fell by 44.8% year-over-year, while orders from the portable power supply sector and Indian 2- and 3-wheeler manufacturers grew significantly.
Geographic Expansion: The company is targeting high-quality European and American customers and expanding market share in India and the portable power supply industry.
Revenue Decline: Net revenue declined by 15% year-over-year to $40.52 million, primarily due to reduced sales of Model 26650 cells.
Hitrans Performance: Hitrans' net revenues increased by 59.36% to $19.43 million, and net losses narrowed by 33.02% to $1.06 million, driven by new customer acquisitions and lower raw material prices.
Overseas Manufacturing: The Malaysian project has been temporarily paused due to ongoing U.S.-China tariff negotiations. Establishing U.S. battery cell production remains a long-term goal.
Transition to Model 40135: The transition from Model 26650 to Model 40135 at the Dalian facility has caused a sharp decline in net revenues and gross profit, significantly impacting consolidated results.
Supply Constraints at Nanjing Facility: The Nanjing facility is operating at full capacity due to surging demand for Model 32140 cells, and the delay in Phase 2 expansion to Q4 limits the ability to fulfill additional orders.
Decline in Residential Energy Storage Market: Sales to customers in the residential energy storage market fell by 44.8% year-over-year, contributing to a 15% decline in net revenue.
Paused Malaysian Project: The relocation of manufacturing lines overseas in response to U.S. tariffs has been paused, creating uncertainty in the company's strategic plans.
Net Losses: The company reported net losses of $3.07 million attributable to shareholders, with the battery segment accounting for $2.07 million in losses.
Dependence on Phase 2 Nanjing Expansion: The company's ability to meet demand and recover financially is heavily dependent on the timely completion of the Phase 2 Nanjing expansion.
Completion of Model 40135 production line: The Dalian facility is transitioning to the production of Model 40135 cells, which are expected to be ready for mass production by Q3 to Q4 2025. This is anticipated to contribute to a strong recovery in consolidated results by year-end.
Nanjing Phase 2 expansion: The completion of Phase 2 of the Nanjing plant, delayed to Q4 2025, will address the current supply constraints and enable the company to fulfill additional pending orders, supporting a recovery in financial performance.
Market strategy: The company plans to target high-quality European and American customers for its Model 26650, 32140, and upcoming 40135 cells, while expanding its market share in India and the portable power supply industry.
Overseas manufacturing strategy: The company has temporarily paused its Malaysian project due to ongoing U.S.-China tariff negotiations but remains committed to establishing battery cell production capacity in the U.S. as part of its long-term strategy.
Hitrans performance outlook: Hitrans is expected to continue expanding its market presence and customer base, driving growth in raw material sales. Combined with a recovery in raw material prices, this is projected to contribute to a rebound in financial performance.
The selected topic was not discussed during the call.
The earnings call reveals strong financial performance with significant year-over-year growth in consolidated revenue and net income, driven by recovering raw material prices and strong demand for specific battery models. Despite risks like overcapacity and regulatory hurdles, the company is making strategic expansions and has positive market outlooks. The Q&A section indicates positive sentiment from analysts, with clear responses from management. Overall, the positive financial results, coupled with optimistic future projections and strategic expansions, suggest a positive stock price movement over the next two weeks.
The earnings call reveals several negative indicators: a significant net loss, declining revenue, and strategic uncertainties due to paused projects and supply constraints. The Q&A session highlighted competitive pressures and uncertain timelines for new product development. Although Hitrans showed revenue growth, it was insufficient to offset overall losses. The absence of a clear shareholder return plan and the dependency on delayed expansions further dampen sentiment. These factors, coupled with a strategic transition impacting revenues, suggest a negative stock price reaction in the short term.
The earnings call reveals significant challenges: a 41% revenue decline, a net loss compared to last year's net income, and heavy dependency on a large customer order. While there are positive strategic shifts and product upgrades, these are long-term and overshadowed by immediate financial instability and risks. The lack of a share buyback program and unclear management responses further contribute to a negative sentiment. Although there is potential for future growth, the current outlook is bleak, suggesting a negative stock price reaction in the short term.
The earnings call reveals significant challenges: a substantial revenue decline, net loss, and dependency on customer agreements for future expansion. While there are positive aspects like potential recovery with new product lines and overseas expansion, the financial instability and unclear management responses overshadow these. The Q&A section highlights customer-driven decisions but lacks clarity on execution timelines. Given these factors, the stock price is likely to experience a negative reaction in the short term, potentially falling within the -2% to -8% range.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
